Lexaria Bioscience (LEXX) EBITDA (2017 - 2026)
Lexaria Bioscience's EBITDA was -$1.97 million in fiscal Q3 2026 (quarter ended May 31, 2026), compared with -$3.72 million a year earlier.
Powered by 
Analysis
Lexaria Bioscience (LEXX) EBITDA (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Lexaria Bioscience's EBITDA was -$7.69 million through May 31, 2026; for FY2025 (ended Aug 31, 2025), it was -$11.88 million.
- In earlier fiscal years, EBITDA was -$5.68 million in FY2024, -$6.39 million in FY2023, -$6.52 million in FY2022 and -$5.58 million in FY2021.
- Quarterly EBITDA has moved between -$3.72 million (fiscal Q3 2025) and -$652,074 (fiscal Q2 2024) over five years.
- Per Business Quant data, LEXX's EBITDA in the three fiscal quarters before Q3 2026 was -$1.43 million (Q2 2026), -$1.53 million (Q1 2026) and -$2.76 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Lexaria Bioscience | 2.58 Mn | -12.67 Mn | - | -1.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -1.97 Mn |
| Feb 28, 2026 | -1.43 Mn |
| Nov 30, 2025 | -1.53 Mn |
| Aug 31, 2025 | -2.76 Mn |
| May 31, 2025 | -3.72 Mn |
| Feb 28, 2025 | -2.75 Mn |
| Nov 30, 2024 | -2.66 Mn |
| Aug 31, 2024 | -2.19 Mn |
| May 31, 2024 | -1.73 Mn |
| Feb 29, 2024 | -652,074.00 |
| Nov 30, 2023 | -1.11 Mn |
| Aug 31, 2023 | -1.04 Mn |
| May 31, 2023 | -2.38 Mn |
| Feb 28, 2023 | -1.30 Mn |
| Nov 30, 2022 | -1.67 Mn |
| Aug 31, 2022 | -723,815.00 |
| May 31, 2022 | -2.39 Mn |
| Feb 28, 2022 | -1.42 Mn |
| Nov 30, 2021 | -1.98 Mn |
| Aug 31, 2021 | -1.27 Mn |
API Access
Lexaria Bioscience EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();